Get the full HIV and Cervical Cancer Screening public health report
The full report covers burden, affected groups, risk factors, screening, treatment coverage, programmes, gaps and outlook, with a source and year for every figure.
| Place | Active trials | Report |
|---|---|---|
| World | 24 | View report |
| Africa | 12 | View report |
 Kenya | 3 | View report |
 Malawi | 0 | View report |
 Mozambique | 1 | View report |
 Nigeria | 2 | View report |
 South Africa | 3 | View report |
 Tanzania | 1 | View report |
 Uganda | 1 | View report |
 Zambia | 1 | View report |
Public clinical research
24 active trials found worldwide on ClinicalTrials.gov.
See the public searchLatest public research
- Preimplementation Factors for a Mobile Decision Support Tool for Cervical Cancer Screening Among Dominican Women Living With HIV: Qualitative Study.The Journal of the Association of Nurses in AIDS Care : JANAC, 2026
- Prevalence and distribution of high-risk human papillomavirus genotypes among women living with HIV in Nigeria.PloS one, 2026
- Potential impact of the United States President's Emergency Plan for AIDS Relief funding cuts on the HIV and cervical cancer burden in Kenya.AIDS (London, England), 2026
- Assessing an educational strategy to improve community health provider-led provision of cervical cancer screening services in western Kenya: A secondary analysis of the Elimisha-HPV cluster-randomized controlled trial.Global health & medicine, 2026
- "We don't know schistosomiasis can affect the female reproductive system and increase the risk of HIV": A mixed-methods analysis reveals gaps in risk factor determinants and health consequences of female genital schistosomiasis in Southern Chad.PLoS neglected tropical diseases, 2026
Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.